KV Pharmaceutical’s Hermelin Resigns After U.S. Ban

KV Pharmaceutical Co. said Marc Hermelin resigned as a director and will sell his controlling interest after being banned from doing business with the U.S. government for two decades. KV rose in New York trading.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.